[EN] VACCINE COMPOSITION<br/>[FR] COMPOSITION DE VACCIN
申请人:CUREVAC AG
公开号:WO2016203025A1
公开(公告)日:2016-12-22
A composition or combination comprising at least a first immunogenic component and at least a second adjuvant component, wherein the first immunogenic component comprises at least one nucleic acid molecule encoding at least one epitope of at least one antigen, and wherein the second adjuvant component comprises at least one immune potentiator compound and/or at least one delivery system compound.